[68 Ga]Ga-FAPI versus [18F]F-FDG in malignant melanoma: complementary or counterpoint?
| dc.contributor.author | Mokoala, Kgomotso M.G. | |
| dc.contributor.author | Emil, Novruzov | |
| dc.contributor.author | Lawal, Ismaheel Opeyemi | |
| dc.contributor.author | Antke, Christina | |
| dc.contributor.author | Giesel, Frederik L. | |
| dc.contributor.author | Sathekge, Mike Machaba | |
| dc.contributor.email | mike.sathekge@up.ac.za | en_US |
| dc.date.accessioned | 2022-07-22T07:59:39Z | |
| dc.date.issued | 2022-06 | |
| dc.description.abstract | No abstract available. | en_US |
| dc.description.department | Nuclear Medicine | en_US |
| dc.description.embargo | 2023-02-09 | |
| dc.description.librarian | dm2022 | en_US |
| dc.description.uri | https://www.springer.com/journal/259 | en_US |
| dc.identifier.citation | Mokoala, K., Emil, N., Lawal, I. et al. [68 Ga]Ga-FAPI versus [18F]F-FDG in malignant melanoma: complementary or counterpoint?. European Journal of Nuclear Medicine and Molecular Imaging 49, 2445–2446 (2022). https://doi.org/10.1007/s00259-022-05702-2. | en_US |
| dc.identifier.issn | 1619-7070 (print) | |
| dc.identifier.issn | 1619-7089 (online) | |
| dc.identifier.other | 10.1007/s00259-022-05702-2 | |
| dc.identifier.uri | https://repository.up.ac.za/handle/2263/86394 | |
| dc.language.iso | en | en_US |
| dc.publisher | Springer | en_US |
| dc.rights | © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022. | en_US |
| dc.subject | Fibroblast activation protein (FAP) | en_US |
| dc.subject | Malignant melanoma | en_US |
| dc.title | [68 Ga]Ga-FAPI versus [18F]F-FDG in malignant melanoma: complementary or counterpoint? | en_US |
| dc.type | Postprint Article | en_US |